prednisone has been researched along with Labor, Premature in 12 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| "We compared the use of aspirin alone with combined therapy (prednisone plus aspirin) in antiphospholipid antibody-positive obstetric patients with prior adverse pregnancy outcome." | 5.07 | Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. ( Hobart, JM; MacGregor, SN; Neerhof, MG; Ragin, A; Sholl, JS; Silver, RK, 1993) |
| "A pregnant patient developed fulminant polymyositis with myoglobinuria after terbutaline and magnesium sulfate tocolysis." | 4.77 | Polymyositis with myoglobinuria in pregnancy: a report and review of the literature. ( Ditzian-Kadanoff, R; Reinhard, JD; Segal, AS; Thomas, C, 1988) |
| " We recorded demographic data, disease activity (SLE Disease Activity Index, SLEDAI), obstetric history, prednisone dosage, other medications taken during pregnancy, history of renal disease, and autoantibody status [including antinuclear antibody, anti-DNA, anticardiolipin IgG (aCL), and lupus anticoagulant (LAC)]." | 3.72 | Preterm deliveries in women with systemic lupus erythematosus. ( Clark, CA; Laskin, CA; Nadler, JN; Spitzer, KA, 2003) |
| "An autoimmune disease was present in seven (29%) cases." | 1.42 | Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015) |
| "Pregnancy was authorized if disease was inactive on 20 mg/day prednisone or less for at least 1 yr." | 1.30 | Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. ( Blétry, O; Darbois, Y; Godeau, P; Lê Huong, D; Lefèbvre, G; Piette, JC; Seebacher, J; Vauthier-Brouzes, D; Wechsler, B, 1997) |
| "Mean birth weight was 2." | 1.28 | [Pregnancy after renal transplantation. 27 patients and review of the literature]. ( Edouard, D; Fernandez, H; Frydman, R; Ville, Y, 1992) |
| "Most frequent are preeclampsia, premature labour, foetal maldevelopment and flare-ups of the underlying disease." | 1.28 | [Systemic lupus erythematosus and pregnancy. Clinical aspects, serology and management]. ( DuBois, A; Hillemanns, HG; Kerl, J; Quaas, L; Röther, E; Runge, HM, 1990) |
| "Pregnancy was best tolerated by mothers without significant nephropathy or cardiopathy who had been in clinical remission for more than three months prior to conception." | 1.26 | Systemic lupus erythematosus in pregnancy. ( Devoe, LD; Taylor, RL, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mekinian, A | 1 |
| Costedoat-Chalumeau, N | 1 |
| Masseau, A | 1 |
| Botta, A | 1 |
| Chudzinski, A | 1 |
| Theulin, A | 1 |
| Emmanuelli, V | 1 |
| Hachulla, E | 1 |
| De Carolis, S | 1 |
| Revaux, A | 1 |
| Nicaise, P | 1 |
| Cornelis, F | 1 |
| Subtil, D | 1 |
| Montestruc, F | 1 |
| Bucourt, M | 1 |
| Chollet-Martin, S | 1 |
| Carbillon, L | 1 |
| Fain, O | 1 |
| Sung, N | 1 |
| Byeon, HJ | 1 |
| Garcia, MDS | 1 |
| Skariah, A | 1 |
| Wu, L | 1 |
| Dambaeva, S | 1 |
| Beaman, K | 1 |
| Gilman-Sachs, A | 1 |
| Kwak-Kim, J | 1 |
| Klehmet, J | 1 |
| Dudenhausen, J | 1 |
| Meisel, A | 1 |
| Clark, CA | 1 |
| Spitzer, KA | 1 |
| Nadler, JN | 1 |
| Laskin, CA | 2 |
| Silver, RK | 1 |
| MacGregor, SN | 1 |
| Sholl, JS | 1 |
| Hobart, JM | 1 |
| Neerhof, MG | 1 |
| Ragin, A | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Lê Huong, D | 1 |
| Wechsler, B | 1 |
| Vauthier-Brouzes, D | 1 |
| Seebacher, J | 1 |
| Lefèbvre, G | 1 |
| Blétry, O | 1 |
| Darbois, Y | 1 |
| Godeau, P | 1 |
| Piette, JC | 1 |
| Devoe, LD | 1 |
| Taylor, RL | 1 |
| Ville, Y | 1 |
| Fernandez, H | 1 |
| Edouard, D | 1 |
| Frydman, R | 1 |
| Cowchock, FS | 1 |
| Reece, EA | 1 |
| Balaban, D | 1 |
| Branch, DW | 1 |
| Plouffe, L | 1 |
| Runge, HM | 1 |
| Röther, E | 1 |
| Kerl, J | 1 |
| DuBois, A | 1 |
| Quaas, L | 1 |
| Hillemanns, HG | 1 |
| Ditzian-Kadanoff, R | 1 |
| Reinhard, JD | 1 |
| Thomas, C | 1 |
| Segal, AS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Labor, Premature
| Article | Year |
|---|---|
[Course and treatment of myasthenia gravis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Arthrogryposis; Autoantibodies; Breast Feeding; Cesarean Section; C | 2010 |
Polymyositis with myoglobinuria in pregnancy: a report and review of the literature.
Topics: Adult; Female; Humans; Magnesium Sulfate; Myoglobinuria; Myositis; Obstetric Labor, Premature; Predn | 1988 |
3 trials available for prednisone and Labor, Premature
| Article | Year |
|---|---|
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; F | 1993 |
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Female; Fetal Membranes, Premature Rupture; Heparin; | 1992 |
7 other studies available for prednisone and Labor, Premature
| Article | Year |
|---|---|
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Vi | 2015 |
Deficiency in memory B cell compartment in a patient with infertility and recurrent pregnancy losses.
Topics: Abortion, Habitual; Adult; Antigens, CD19; B-Lymphocyte Subsets; B-Lymphocytes; Female; Humans; Immu | 2016 |
Preterm deliveries in women with systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Female; Humans; Infant, Newborn; Lupus Erythe | 2003 |
Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies.
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Systemic lupus erythematosus in pregnancy.
Topics: Abortion, Induced; Abortion, Missed; Azathioprine; Female; Humans; Infant, Newborn; Lupus Erythemato | 1979 |
[Pregnancy after renal transplantation. 27 patients and review of the literature].
Topics: Adult; Azathioprine; Birth Weight; Cesarean Section; Cyclosporine; Drug Therapy, Combination; Female | 1992 |
[Systemic lupus erythematosus and pregnancy. Clinical aspects, serology and management].
Topics: Antibodies, Antinuclear; Azathioprine; Female; Fetal Death; Humans; Infant, Newborn; Lupus Erythemat | 1990 |